m+Medelevator.RU
← Поиск публикаций
Journal of public health management and practice : JPHMP · 2026

A Return-On-Investment Analysis for Lead Poisoning Case Management in New York City.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Goldwater Jason C, Harris Yael M, Neustrom Kyle W, Sedlar Slavenka, Ehrlich Jacqueline, Faciano Andrew

Аннотация

OBJECTIVES: To evaluate the return on investment (ROI) and social return on investment (SROI) of childhood lead poisoning case management in New York City by quantifying direct cost savings and long-term societal benefits associated with intervention among children with elevated blood lead levels.

DESIGN: Mixed-methods economic modeling study estimating ROI and SROI using program cost data, published outcome valuations, and sensitivity analyses for 1462 high-risk NYC children.

SETTING: New York City Department of Health-led lead poisoning case management program serving high-risk children in urban housing.

PARTICIPANTS: One thousand four hundred sixty two New York City children with blood lead levels ≥10 μg/dL who received case management and environmental inspections.

INTERVENTION: Public health nurse-led case management, including home inspections, lead hazard remediation coordination, medical monitoring, and family support services.

MAIN OUTCOME MEASURE: ROI and SROI, including avoided medical, education, productivity, justice, and quality-of-life costs.

RESULTS: Baseline ROI was 1.34 ($2.34 saved per $1 invested); SROI was 26.37, reflecting more than $98 million in lifetime societal benefits for the full cohort of 1462 children.

CONCLUSIONS: Lead poisoning case management generates substantial economic and societal returns, supporting sustained investment as a high-impact, equity-focused public health strategy.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты